Literature DB >> 18657842

Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.

Michael D Moore1, William Fu, Ferri Soheilian, Kunio Nagashima, Roger G Ptak, Vinay K Pathak, Wei-Shau Hu.   

Abstract

Protease activity within nascently released human immunodeficiency virus type 1 (HIV-1) particles is responsible for the cleavage of the viral polyproteins Gag and Gag-Pol into their constituent parts, which results in the subsequent condensation of the mature conical core surrounding the viral genomic RNA. Concomitant with viral maturation is a conformational change in the packaged viral RNA from a loosely associated dimer into a more thermodynamically stable form. In this study we used suboptimal concentrations of two protease inhibitors, lopinavir and atazanavir, to study their effects on Gag polyprotein processing and on the properties of the RNA in treated virions. Analysis of the treated virions demonstrated that even with high levels of inhibition of viral infectivity (IC(90)), most of the Gag and Gag-Pol polyproteins were processed, although slight but significant increases in processing intermediates of Gag were detected. Drug treatments also caused a significant increase in the proportion of viruses displaying either immature or aberrant mature morphologies. The aberrant mature particles were characterized by an electron-dense region at the viral periphery and an electron-lucent core structure in the viral center, possibly indicating exclusion of the genomic RNA from these viral cores. Intriguingly, drug treatments caused only a slight decrease in overall thermodynamic stability of the viral RNA dimer, suggesting that the dimeric viral RNA was able to mature in the absence of correct core condensation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657842      PMCID: PMC2577075          DOI: 10.1016/j.virol.2008.06.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Image reconstructions of helical assemblies of the HIV-1 CA protein.

Authors:  S Li; C P Hill; W I Sundquist; J T Finch
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

2.  The stoichiometry of Gag protein in HIV-1.

Authors:  John A G Briggs; Martha N Simon; Ingolf Gross; Hans-Georg Kräusslich; Stephen D Fuller; Volker M Vogt; Marc C Johnson
Journal:  Nat Struct Mol Biol       Date:  2004-06-20       Impact factor: 15.369

3.  A procedure for Northern blot analysis of native RNA.

Authors:  E W Khandjian; C Méric
Journal:  Anal Biochem       Date:  1986-11-15       Impact factor: 3.365

4.  Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

Authors:  A H Kaplan; J A Zack; M Knigge; D A Paul; D J Kempf; D W Norbeck; R Swanstrom
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.

Authors:  Dimiter G Demirov; Jan M Orenstein; Eric O Freed
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.

Authors:  Y X Feng; T D Copeland; L E Henderson; R J Gorelick; W J Bosche; J G Levin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Ultrastructure of human retroviruses.

Authors:  E Palmer; C S Goldsmith
Journal:  J Electron Microsc Tech       Date:  1988-01

10.  Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.

Authors:  Steve C Pettit; Jeffrey N Lindquist; Andrew H Kaplan; Ronald Swanstrom
Journal:  Retrovirology       Date:  2005-11-01       Impact factor: 4.602

View more
  19 in total

1.  RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.

Authors:  Simone Mattei; Annica Flemming; Maria Anders-Össwein; Hans-Georg Kräusslich; John A G Briggs; Barbara Müller
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  Maturation of retroviruses.

Authors:  Owen Pornillos; Barbie K Ganser-Pornillos
Journal:  Curr Opin Virol       Date:  2019-06-08       Impact factor: 7.090

3.  HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.

Authors:  Barbara Müller; Maria Anders; Hisashi Akiyama; Sonja Welsch; Bärbel Glass; Krisztina Nikovics; Francois Clavel; Hanna-Mari Tervo; Oliver T Keppler; Hans-Georg Kräusslich
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

4.  Zinc Fingers in HIV-1 Gag Precursor Are Not Equivalent for gRNA Recruitment at the Plasma Membrane.

Authors:  Emmanuel Boutant; Jeremy Bonzi; Halina Anton; Maaz Bin Nasim; Raphael Cathagne; Eléonore Réal; Denis Dujardin; Philippe Carl; Pascal Didier; Jean-Christophe Paillart; Roland Marquet; Yves Mély; Hugues de Rocquigny; Serena Bernacchi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

5.  Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates.

Authors:  Maria C Puertas; Maria J Buzón; Mònica Ballestero; Peter Van Den Eede; Bonaventura Clotet; Julia G Prado; Javier Martinez-Picado
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

6.  A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.

Authors:  Marc Potempa; Ellen Nalivaika; Debra Ragland; Sook-Kyung Lee; Celia A Schiffer; Ronald Swanstrom
Journal:  J Mol Biol       Date:  2015-05-15       Impact factor: 5.469

7.  A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.

Authors:  Sook-Kyung Lee; Janera Harris; Ronald Swanstrom
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.

Authors:  Kellie A Jurado; Hao Wang; Alison Slaughter; Lei Feng; Jacques J Kessl; Yasuhiro Koh; Weifeng Wang; Allison Ballandras-Colas; Pratiq A Patel; James R Fuchs; Mamuka Kvaratskhelia; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

9.  Cryo electron tomography of native HIV-1 budding sites.

Authors:  Lars-Anders Carlson; Alex de Marco; Heike Oberwinkler; Anja Habermann; John A G Briggs; Hans-Georg Kräusslich; Kay Grünewald
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

Review 10.  Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors.

Authors:  Kellie Ann Jurado; Alan Engelman
Journal:  Expert Rev Mol Med       Date:  2013-11-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.